EE200200576A - Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena - Google Patents

Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena

Info

Publication number
EE200200576A
EE200200576A EEP200200576A EEP200200576A EE200200576A EE 200200576 A EE200200576 A EE 200200576A EE P200200576 A EEP200200576 A EE P200200576A EE P200200576 A EEP200200576 A EE P200200576A EE 200200576 A EE200200576 A EE 200200576A
Authority
EE
Estonia
Prior art keywords
tyrosine kinase
kinase inhibitors
oxazole derivatives
oxazole
derivatives
Prior art date
Application number
EEP200200576A
Other languages
English (en)
Inventor
Tasaka Akihiro
Hitaka Takenori
Matsutani Etsuya
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of EE200200576A publication Critical patent/EE200200576A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200576A 2000-04-07 2001-04-05 Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena EE200200576A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000106836 2000-04-07
PCT/JP2001/002937 WO2001077107A1 (en) 2000-04-07 2001-04-05 Oxazole derivatives and their uses as tyrosine kinase inhibitors

Publications (1)

Publication Number Publication Date
EE200200576A true EE200200576A (et) 2004-06-15

Family

ID=18619943

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200576A EE200200576A (et) 2000-04-07 2001-04-05 Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena

Country Status (19)

Country Link
US (2) US6716863B2 (et)
EP (1) EP1268473A1 (et)
KR (1) KR20020028865A (et)
CN (1) CN1444582A (et)
AU (1) AU2001244726A1 (et)
BR (1) BR0109851A (et)
CA (1) CA2404760A1 (et)
CO (1) CO5261589A1 (et)
CZ (1) CZ20023264A3 (et)
EE (1) EE200200576A (et)
HU (1) HUP0300434A3 (et)
IL (1) IL152115A0 (et)
MX (1) MXPA02009621A (et)
NO (1) NO20024742L (et)
OA (1) OA12244A (et)
PE (1) PE20011178A1 (et)
PL (1) PL365787A1 (et)
SK (1) SK14132002A3 (et)
WO (1) WO2001077107A1 (et)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020034A1 (fr) * 1998-10-08 2000-04-13 Takeda Chemical Industries, Ltd. Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant
EP1310491A1 (en) * 2000-07-19 2003-05-14 Takeda Chemical Industries, Ltd. Method for producing 1-substituted-1,2,3-triazole derivative
US20040235748A1 (en) * 2001-04-25 2004-11-25 Yasutaka Igari Agents for preventing postoperative recurrence of premenopausal breast cancer
WO2002087619A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
WO2002087618A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
US20050215528A1 (en) * 2001-08-10 2005-09-29 Shuichi Furuya Gnrh agonist combination drugs
US6984653B2 (en) * 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
US7812044B2 (en) 2001-11-13 2010-10-12 Takeda Pharmaceutical Company Limited Anticancer agents
EP1460067A4 (en) * 2001-11-26 2005-12-07 Takeda Pharmaceutical BICYCLIC DERIVATIVE, PROCESS FOR PRODUCTION OF THE DERIVATIVE, AND USE THEREOF
WO2003059907A1 (fr) * 2002-01-17 2003-07-24 Takeda Chemical Industries, Ltd. Composes heterocycliques azotes : procede de preparation et d'utilisation
RU2376029C2 (ru) 2002-04-25 2009-12-20 Юниверсити Оф Коннектикут Хелт Сентер Применение белков теплового шока для улучшения терапевтического эффекта невакцинного лечебного воздействия
KR101072909B1 (ko) * 2002-12-16 2011-10-17 깃세이 야쿠힌 고교 가부시키가이샤 경구고형의약
TW200505913A (en) * 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
TW200423931A (en) * 2003-04-30 2004-11-16 Hoffmann La Roche Novel aniline derivatives, their manufacture and use as pharmaceutical agents
US7247649B2 (en) 2003-08-13 2007-07-24 Hoffmann-La Roche Inc. Oxazoles, their manufacture and use as pharmaceutical agents
US7259262B2 (en) * 2003-10-24 2007-08-21 Hoffmann-La Roche Inc. Arylazole derivatives, their manufacture and use as pharmaceutical agents
US20050186275A1 (en) * 2004-02-23 2005-08-25 Standard Chem. & Pharm. Co. Ltd. Sustained release tamsulosin formulations
TW200612914A (en) * 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200531688A (en) 2004-03-05 2005-10-01 Hoffmann La Roche Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
TW200533346A (en) * 2004-03-18 2005-10-16 Hoffmann La Roche Novel ether derivatives, their manufacture and use as pharmaceutical agents
EP1758897A1 (en) 2004-04-02 2007-03-07 F.Hoffmann-La Roche Ag Novel diazine derivatives, their manufacture and use as pharmaceutical agents
US7005526B2 (en) * 2004-05-25 2006-02-28 Hoffmann-La Roche Inc. Thioether derivatives
US7163953B2 (en) * 2004-05-25 2007-01-16 Hoffmann-La Roche Inc. Benzylether derivatives
US7618769B2 (en) * 2004-06-07 2009-11-17 Applied Materials, Inc. Textured chamber surface
US7288557B2 (en) 2004-09-21 2007-10-30 Hoffmann-La Roche Inc. Triazole derivatives
US7342030B2 (en) * 2004-09-22 2008-03-11 Hoffmann-La Roche Inc. Indole derivatives
US20060069095A1 (en) * 2004-09-24 2006-03-30 Thomas Hofmeister Azole derivatives
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
TW200738680A (en) * 2005-08-04 2007-10-16 Hoffmann La Roche Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
CA2616075A1 (en) * 2005-08-08 2007-02-15 Hans-Willi Krell Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
US20090093491A1 (en) * 2005-09-30 2009-04-09 Wolfgang Jenni Diazine Azole Derivatives, Their Manufacture and Use as Pharmaceutical
WO2008034579A1 (en) * 2006-09-20 2008-03-27 F. Hoffmann-La Roche Ag 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents
EP2103620A1 (en) 2006-12-12 2009-09-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
EP2140883B1 (en) 2007-04-20 2012-10-31 Daido Chemical Corporation Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion
US20090233937A1 (en) 2008-03-12 2009-09-17 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
AR073680A1 (es) * 2008-09-26 2010-11-24 Takeda Pharmaceutical Prevencion y tratamiento de cancer con la mutacion del gen ras. composicion farmaceutica. uso.
WO2010036928A1 (en) * 2008-09-26 2010-04-01 Takeda Pharmaceutical Company Limited Prevention and treatment of cancer with lkb1 non-expression (deletion or mutation)
EP2484383B1 (en) 2009-09-30 2021-04-28 Kabushiki Kaisha Sangi Method for improving the aqueous solubility of poorly-soluble substances
JP5705206B2 (ja) 2010-02-26 2015-04-22 日新化成株式会社 硬カプセルおよびその製造方法
WO2011153050A1 (en) 2010-06-02 2011-12-08 The Trustees Of The University Of Pennsylvania Methods and use of compounds that bind to her2/neu receptor complex
US8993634B2 (en) 2010-06-02 2015-03-31 The Trustees Of The University Of Pennsylvania Methods and use of compounds that bind to Her2/neu receptor complex
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
EP2902014B1 (en) 2012-09-26 2019-03-06 Takeda Pharmaceutical Company Limited Process for producing solid particles
US9468681B2 (en) 2013-03-01 2016-10-18 California Institute Of Technology Targeted nanoparticles
EP3317323B1 (en) 2015-07-01 2021-05-26 California Institute of Technology Cationic mucic acid polymer-based delivery systems
EP3238711B1 (en) 2016-04-26 2023-07-12 Mitsubishi Chemical Corporation Base for solid dispersion, production method for solid dispersion using same, and solid dispersion
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof
CA3099440A1 (en) 2018-06-13 2019-12-19 California Institute Of Technology Nanoparticles for crossing the blood brain barrier and methods of treatment using the same
WO2020130125A1 (ja) 2018-12-21 2020-06-25 第一三共株式会社 抗体-薬物コンジュゲートとキナーゼ阻害剤の組み合わせ
CN118767143A (zh) 2019-12-12 2024-10-15 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法
CN114217025B (zh) * 2021-12-17 2024-01-23 哈尔滨工业大学 评估空气质量浓度预测中气象数据对其影响的分析方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658567B2 (en) 1990-04-16 1995-04-27 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted indole and pyridyl compounds
EP0912562A1 (en) * 1996-07-19 1999-05-06 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
NO20024742D0 (no) 2002-10-02
WO2001077107B1 (en) 2001-12-20
CO5261589A1 (es) 2003-03-31
CA2404760A1 (en) 2001-10-18
MXPA02009621A (es) 2003-05-14
OA12244A (en) 2006-05-10
US6716863B2 (en) 2004-04-06
PE20011178A1 (es) 2001-11-19
PL365787A1 (en) 2005-01-10
BR0109851A (pt) 2003-06-03
EP1268473A1 (en) 2003-01-02
CN1444582A (zh) 2003-09-24
IL152115A0 (en) 2003-05-29
US20040024035A1 (en) 2004-02-05
SK14132002A3 (sk) 2003-04-01
KR20020028865A (ko) 2002-04-17
WO2001077107A8 (en) 2003-02-13
CZ20023264A3 (cs) 2003-02-12
HUP0300434A2 (hu) 2003-06-28
AU2001244726A1 (en) 2001-10-23
WO2001077107A1 (en) 2001-10-18
NO20024742L (no) 2002-11-25
HUP0300434A3 (en) 2004-11-29
US20020173526A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
EE200200576A (et) Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena
EE200200715A (et) Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
EE200300085A (et) Pürasooli derivaadid ja nende kasutamine proteiini kinaasi inhibiitoritena
DK1000039T3 (da) Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
DK1650203T3 (da) Quinolinonderivater som tyrosinkinaseinhibitorer
NO20021820D0 (no) Tyrosinkinaseinhibitorer
NO20023713D0 (no) 2-benzotiazolyl-urea-derivater samt anvendelse derav som proteinkinaseinhibitorer
EE200300459A (et) Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena
IS6968A (is) Nýir týrósínkínasa tálmar
ATE253576T1 (de) 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren
EE200300071A (et) Kinasoliini derivaadid
NO20014970D0 (no) Cyklisk protein-tyrosin-kinase-inhibitor
IS6524A (is) 5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
EE200100659A (et) Diaminotiasoolid ja nende kasutamine proteiinikinaaside pärssimiseks
ATE269701T1 (de) Gyrase-inhibitoren und ihre verwendung
EE200300491A (et) 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
AR028068A1 (es) Nuevos derivados de 1,1-dioxotiocromano y su uso como inhibidores de trombina
NO20025884D0 (no) 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
IDP000027420A (id) Inhibitor-inhibitor kinase pirolotriazin
AU2002358198A1 (en) Benzimidazole derivatives and their use as kdr protein kinase inhibitors
AU2002317319A1 (en) Quinoline derivatives and their use as tyrosine kinase inhibitors